XR8-89 is a potent papain-like protease (PLpro) inhibitor with an IC50 value of 0.1 µM. XR8-89 induces conformational changes in SARS-COV-2 papain-like protease, inhibiting SARS-CoV-2 replication. XR8-89 can be used for SARS-CoV-2 research[1].
Molecular Weight:
504.69
Purity:
97.41
CAS Number:
[2817811-16-6]
Formula:
C29H36N4O2S
Target:
SARS-CoV
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted